1. Sharp AA. Diagnosis and management of disseminated intravascular coagulation. Br Med Bull. 1977. 33:265–272.
2. Donati MB. Cancer and thrombosis. Haemostasis. 1994. 24:128–131.
3. Sack GH Jr, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patient with neoplasms: clinical, pathologic, and therapeutic features. Medicine. 1977. 56:1–37.
4. Trousseau A. Phlegmasia alba dolens. Clinique mediciale de l'hotel-dieu de Paris. 1865. London: New Sydenham Society;282–332.
5. Naschitz JE, Yeshurun D, Abramson J, Eldar S, Chouri H, Kedar S, et al. Ischemic heart disease precipitated by occult cancer. Cancer. 1992. 69:2712–2720.
6. Bick RL. Cancer-associated thrombosis. N Engl J Med. 2003. 349:109–111.
7. Liu PG, Jacobs JB, Reede D. Trousseau's syndrome in the head and neck. Am J Otolaryngol. 1985. 6:405–408.
8. Vicente Prados EJ, Tallada BM, Pastor J, Martinez MA, Cozar Olmo JM, Espejo ME, et al. Renal adenocarcinoma with vena cava invasion: current status of its diagnosis and treatment using total segmentary cavecromy. Arch Esp Urol. 1998. 51:35–41.
9. Goldenberg N, Kahn SR, Solymoss S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol. 2003. 21:4194–4199.
10. Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ Jr, Forcier RJ, et al. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: final report of Vaterans Administration Cooperative Study #75. Cancer. 1984. 53:2046–2052.
11. Callander N, Rappaport SI. Trousseau's syndrome. West J Med. 1993. 158:364–371.
12. Hines JF, Tucker A, Grendys EC, Ascher SM, Barter JF. Spontaneous preoperative internal jugular and subclavian vein thrombosis associated with an early stage synchronous ovarian/endometrial malignancy. Gynecol Oncol. 1995. 56:298–301.
13. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003. 349:146–153.
14. vander Heijden JF, Hutten BA, Buller HR, Prins MH. Vitamin K antagonist or low-molecular-weight heparin for the longterm treatment of symptomatic venous thromboembolism. Cochrance Database Syst Rev. 2000. (4):CD002001.